Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomas

Carcinogenesis

Volumn 33, Issue 1, 2012, Pages 184-190

  Sand, Jordan M ^a   Hafeez, Bilal Bin ^a   Jamal, Mohammad Sarwar ^a   Witkowsky, Olya ^a   Siebers, Emily M ^a   Fischer, Joseph ^a   Verma, Ajit K ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; CYCLINE; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; P21 ACTIVATED KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLUMBAGIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BCL XL; PROTEIN P27; STAT3 PROTEIN; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; FEMALE; MOUSE; NONHUMAN; PLANT ROOT; PLUMBAGO ZEYLANICA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; WEIGHT GAIN;

EID: 84855378113     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr249     Document Type: Article

References (34)

1. Jemal,A. et al. (2009) Cancer statistics, 2009. CA Cancer J. Clin., 59, 225-249.
2. Armstrong,B.K. et al. (2001) The epidemiology of UVinduced skin cancer. J. Photochem. Photobiol. B, 63, 8-18.
3. de Gruijl,F.R. (2002) Photocarcinogenesis: UVA vs. UVB radiation. Skin Pharmacol. Appl. Skin Physiol., 15, 316-320.
4. Nguyen,T.H. et al. (2002) Nonmelanoma skin cancer. Curr. Treat. Options Oncol., 3, 193-203.
5. Cooper,S.J. et al. (2007) Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. Curr. Cancer Drug Targets, 7, 325-334.
6. Molho-Pessach,V. et al. (2007) Ultraviolet radiation and cutaneous carcinogenesis. Curr. Probl. Dermatol., 35, 14-27.
7. Wheeler,D.L. et al. (2004) Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas. Cancer Res., 64, 7756-7765.
8. Sandur,S.K. et al. (2006) Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J. Biol. Chem., 281, 17023-17033.
9. Sugie,S. et al. (1998) Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett., 127, 177-183.
10. Kuo,P.L. et al. (2006) Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol. Cancer Ther., 5, 3209-3221.
11. Hsu,Y.L. et al. (2006) Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J. Pharmacol. Exp. Ther., 318, 484-494.
12. Wang,C.C. et al. (2008) Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett., 259, 82-98.
13. Powolny,A.A. et al. (2008) Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species. Pharm. Res., 25, 2171-2180.
14. Aziz,M.H. et al. (2008) Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res., 68, 9024-9032.
15. Sandur,S.K. et al. (2010) 5-Hydroxy-2-methyl-1,4-naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: potential role in chemosensitization. Mol. Cancer Res., 8, 107-118.
16. Son,T.G. et al. (2010) Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia. J. Neurochem., 112, 1316-1326.
17. Ravindra,K.C. et al. (2009) Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin. J. Biol. Chem., 284, 24453-24464.
18. Lai,L. et al. (2011) Plumbagin inhibits tumor angiogenesis and tumor growth through VEGFR2-mediated Ras signaling pathway. Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2011.01532.x.[Epub ahead of print].
19. Aziz,M.H. et al. (2007) Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res., 67, 8828-8838.
20. Sano,S. et al. (2008) Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J. Dermatol. Sci., 50, 1-14.
21. Parimala,R. et al. (1993) Effect of plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma. Mol. Cell Biochem., 125, 59-63.
22. Azad Chowdhury,A.K. et al. (1982) Antifertility activity of Plumbago zeylanica Linn. root. Indian J. Med. Res., 76 (suppl.), 99-101.
23. Li,L. et al. (2004) A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress. Biochem. Biophys. Res. Commun., 322, 1005-1011.
24. Chan,K.S. et al. (2004) Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res., 64, 2382-2389.
25. Akira,S. (2000) Roles of STAT3 defined by tissue-specific gene targeting. Oncogene, 19, 2607-2611.
26. Aziz,M.H. et al. (2007) Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Cancer Res., 67, 1385-1394.
27. Thasni,K.A. et al. (2008) Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents. Ann. Oncol., 19, 696-705.
28. Srinivas,P. et al. (2004) Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells. Mol. Carcinog., 40, 201-211.
29. Ahmad,A. et al. (2008) Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2. J. Cell Biochem., 105, 1461-1471.
30. Kawiak,A. et al. (2007) Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II. Toxicol. Appl. Pharmacol., 223, 267-276.
31. Mantena,S.K. et al. (2005) Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors. Photochem. Photobiol., 81, 1174-1179.
32. Aziz,M.H. et al. (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J., 19, 1193-1195.
33. Mallikarjuna,G. et al. (2004) Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res., 64, 6349-6356.
34. Padhye,S. et al. (2010) Perspectives on medicinal properties of plumbagin and its analogs. Med. Res. Rev., 9. [Epub ahead of print].